The Sickening Politics Of Vaccine Legislation
Story from BusinessWeek suggests that limited liability protections are in the cards to encourage development of at least certain types of high-priority vaccines in the U.S. Let’s hope so. It’s overdo. Hell…I predicted it as a key event for 2005; it would suck to count this one as a loss when I do the year-end tally in January. But, seriously, putting a cap on industry’s liability for high-priority vaccines will provide the impetus for manufatcuring capex and R&D investments that some companies are undoubtedly anticipating.
